Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11733994 | 0.76 | LMNA (0.43) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL3877478 | 0.75 | LMNA (0.48) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL4555960 | 0.75 | AKR1B1 (0.39) | SLC22A6TSHRHDAC11KMT2AGPR84 | |
| SCHEMBL3361168 | 0.75 | LMNA (0.48) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL1751918 | 0.75 | LMNA (0.48) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL1032545 | 0.74 | LMNA (0.53) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL5149403 | 0.74 | LMNA (0.53) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL8202305 | 0.74 | LMNA (0.53) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL10919501 | 0.73 | CAMK2A (0.46) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL28456788 | 0.73 | TSHR (0.50) | LMNASLC22A6TSHRNFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160199534-A1 | DRESSING COMPOSITIONS AND METHODS | NIH - DEITR | 2016-07-14 | — | — | US | claimed |
| US-9211358-B2 | Dressing compositions and methods | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-12-15 | — | — | US | claimed |
| US-20110033503-A1 | DRESSING COMPOSITIONS AND METHODS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-02-10 | — | — | US | claimed |
| WO-2008133918-A1 | DRESSING COMPOSITIONS AND METHODS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2008-11-06 | — | — | WO | claimed |
| US-6623726-B2 | Wrapping hair in multilayered, deformable sheets of material having a first perforated, deformable, semi-rigid layer, and a second layer containing a thiol reducing composition, shaping, then oxidizing | L'OREAL S.A. (FR) | 2003-09-23 | — | — | US | claimed |
| US-20020094321-A1 | Process for permanent reshaping of hair | L'OREAL, S.A. (FR) | 2002-07-18 | — | — | US | claimed |
| WO-2002043679-A2 | PROCESS FOR PERMANENT RESHAPING OF HAIR | L'OREAL S.A. (FR) | 2002-06-06 | — | — | WO | claimed |
| EP-0455457-A2 | Permanent wave hair composition containing transition metal oxide compounds | UNILEVER PLC (GB) | 1991-11-06 | — | — | EP | claimed |
| US-5061483-A | TO RE-FORM RUPTURED DISULFIDE LINKAGES | CHESEBROUGH-POND'S INC. (US) | 1991-10-29 | — | — | US | claimed |
| EP-4729131-A2 | METHODS FOR FIXING HAIR AND SKIN | Olaplex, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4008306-B1 | METHODS FOR FIXING HAIR AND SKIN | OLAPLEX INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250381425-A1 | METHODS FOR FIXING HAIR AND SKIN | OLAPLEX INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250302704-A1 | METHODS FOR FIXING HAIR AND SKIN | GOLDMAN SACHS BANK USA | 2025-10-02 | — | — | US | disclosed |
| US-12257330-B2 | Hair coloring compositions and methods of use | L'OREAL (FR) | 2025-03-25 | — | — | US | disclosed |
| EP-0395332-A1 | Hair treatment composition | UNILEVER PLC (GB) | 1990-10-31 | — | — | EP | disclosed |
| US-4898726-A | Initiated hair straightening composition and system | JOHNSON PRODUCTS CO., INC. (US) | 1990-02-06 | — | — | US | disclosed |
| US-4812307-A | PERMANENT WAVES | CHESEBROUGH-POND'S INC. (US) | 1989-03-14 | — | — | US | disclosed |
| EP-0305128-A1 | Hair treatment process | UNILEVER PLC (GB) | 1989-03-01 | — | — | EP | disclosed |
| EP-0299764-A2 | Hair treatment product | UNILEVER PLC (GB) | 1989-01-18 | — | — | EP | disclosed |
| US-4297429-A | COMPLEXING A SILVER HALIDE EMULSION AND AN O-MERCAPTOBENZOIC ACID DERIVATIVE; PHOTOLITHOGRAPHY | MITSUBISHI PAPER MILLS, LTD. (JP) | 1981-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302704-A1 | METHODS FOR FIXING HAIR AND SKIN | KRT18, CUTA, COL14A1 | LMNA 434/4885SLC22A6 3313/4885TSHR 4583/4885 |
| US-12257330-B2 | Hair coloring compositions and methods of use | SGMS1, PHOSPHO1, SGMS2 | LMNA 1805/4885SLC22A6 639/4885TSHR 4268/4885 |
| US-20020094321-A1 | Process for permanent reshaping of hair | GPX4, SHMT2, CUTA | LMNA 1658/4885SLC22A6 2531/4885TSHR 3223/4885 |
| US-20250381425-A1 | METHODS FOR FIXING HAIR AND SKIN | CUTA, SUCLG1, TST | LMNA 1250/4885SLC22A6 2810/4885TSHR 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.